Publications
Found 8 results
Filters: Author is R. Santiyanont [Clear All Filters]
“Fimbristylis ovata (Cyperaceae) extract alleviates neuronal degeneration and death through AGEs/RAGE/JNK regulation in human neuroblastoma cell line, SH-SY5Y”, Genetics and Molecular Research, vol. 22, no. 1, 2023.
, “Neuroprotective effect of Amaranthus lividus and Amaranthus tricolor and their effects on gene expression of RAGE during oxidative stress in SH-SY5Y cells”, vol. 15, p. -, 2016.
, , , “Effect of Fimbristylis ovata on receptor for advanced glycation end-products, proinflammatory cytokines, and cell adhesion molecule level and gene expression in U937 and bEnd.3 cell lines”, vol. 14, pp. 3984-3994, 2015.
, “Gene expression profile in breast cancer comprising predictive markers for metastatic risk”, vol. 14, pp. 10929-10936, 2015.
, “Inhibitory effect of alternatively spliced RAGEv1 on the expression of NF-kB and TNF-α in hepatocellular carcinoma cells”, vol. 11, pp. 1712-1720, 2012.
,
Aggarwal BB and Shishodia S (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71: 1397-1421.
http://dx.doi.org/10.1016/j.bcp.2006.02.009
PMid:16563357
Ahmed N (2005). Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21.
http://dx.doi.org/10.1016/j.diabres.2004.09.004
PMid:15620429
Emanuele E, D'Angelo A, Tomaino C, Binetti G, et al. (2005). Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch. Neurol. 62: 1734-1736.
http://dx.doi.org/10.1001/archneur.62.11.1734
PMid:16286548
Falcone C, Emanuele E, D'Angelo A, Buzzi MP, et al. (2005). Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 25: 1032-1037.
http://dx.doi.org/10.1161/01.ATV.0000160342.20342.00
PMid:15731496
Fernandez-Botran R, Crespo FA and Sun X (2002). Soluble cytokine receptors in biological therapy. Expert. Opin. Biol. Ther. 2: 585-605.
http://dx.doi.org/10.1517/14712598.2.6.585
PMid:12171504
Fisker S, Hansen B, Fuglsang J, Kristensen K, et al. (2004). Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur. J. Endocrinol. 150: 773-777.
http://dx.doi.org/10.1530/eje.0.1500773
PMid:15191346
Geroldi D, Falcone C, Emanuele E, D'Angelo A, et al. (2005). Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J. Hypertens. 23: 1725-1729.
http://dx.doi.org/10.1097/01.hjh.0000177535.45785.64
PMid:16093918
Hirata K, Takada M, Suzuki Y and Kuroda Y (2003). Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells. Hepatogastroenterology 50: 1205-1207.
PMid:14571699
Hiwatashi K, Ueno S, Abeyama K, Kubo F, et al. (2008). A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC. Ann. Surg. Oncol. 15: 923-933.
http://dx.doi.org/10.1245/s10434-007-9698-8
PMid:18080716 PMCid:2234441
Hofmann MA, Drury S, Fu C, Qu W, et al. (1999). RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
http://dx.doi.org/10.1016/S0092-8674(00)80801-6
Hori O, Brett J, Slattery T, Cao R, et al. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270: 25752-25761.
PMid:7592757
Hudson BI, Carter AM, Harja E, Kalea AZ, et al. (2008). Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22: 1572-1580.
http://dx.doi.org/10.1096/fj.07-9909com
PMid:18089847
Kalea AZ, See F, Harja E, Arriero M, et al. (2010). Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling. Cancer Res. 70: 5628-5638.
http://dx.doi.org/10.1158/0008-5472.CAN-10-0595
PMid:20570900 PMCid:2919303
Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, et al. (2005). Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 28: 2716-2721.
http://dx.doi.org/10.2337/diacare.28.11.2716
PMid:16249545
Koyama H, Shoji T, Yokoyama H, Motoyama K, et al. (2005). Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25: 2587-2593.
http://dx.doi.org/10.1161/01.ATV.0000190660.32863.cd
PMid:16224056
Lander HM, Tauras JM, Ogiste JS, Hori O, et al. (1997). Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272: 17810-17814.
http://dx.doi.org/10.1074/jbc.272.28.17810
PMid:9211935
Neeper M, Schmidt AM, Brett J, Yan SD, et al. (1992). Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
PMid:1378843
Neumann A, Schinzel R, Palm D, Riederer P, et al. (1999). High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression. FEBS Lett. 453: 283-287.
http://dx.doi.org/10.1016/S0014-5793(99)00731-0
Pullerits R, Bokarewa M, Dahlberg L and Tarkowski A (2005). Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res. Ther. 7: R817-R824.
http://dx.doi.org/10.1186/ar1749
PMid:15987483 PMCid:1175032
Rojas A and Morales MA (2004). Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 76: 715-730.
http://dx.doi.org/10.1016/j.lfs.2004.09.011
PMid:15581904
Rojas A, Figueroa H and Morales E (2010). Fueling inflammation at tumor microenvironment: the role of multiligand/ RAGE axis. Carcinogenesis 31: 334-341.
http://dx.doi.org/10.1093/carcin/bgp322
PMid:20028726
Schmidt AM, Yan SD, Yan SF and Stern DM (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955.
PMid:11581294 PMCid:200958
Taguchi A, Blood DC, del TG, Canet A, et al. (2000). Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
http://dx.doi.org/10.1038/35012626
PMid:10830965
Yan SD, Schmidt AM, Anderson GM, Zhang J, et al. (1994). Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269: 9889-9897.
PMid:8144582
Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, et al. (2003). Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370: 1097-1109.
http://dx.doi.org/10.1042/BJ20021371
PMid:12495433 PMCid:1223244
“Semi-quantitative detection of gene expression using bisbenzimide dye”, vol. 10. pp. 3747-3759, 2011.
,
Ahmed MU, Idegami K, Chikae M, Kerman K, et al. (2007). Electrochemical DNA biosensor using a disposable electrochemical printed (DEP) chip for the detection of SNPs from unpurified PCR amplicons. Analyst 132: 431-438.
http://dx.doi.org/10.1039/b615242b
PMid:17471389
Ahmed MU, Hasan Q, Hossain MM, Saito M, et al. (2010). Meat species identification based on the loop mediated isothermal amplification and electrochemical DNA sensor. Food Control 21: 599-605.
http://dx.doi.org/10.1016/j.foodcont.2009.09.001
Bernard PS and Wittwer CT (2002). Real-time PCR technology for cancer diagnostics. Clin. Chem. 48: 1178-1185.
PMid:12142370
Chaumpluk P, Chikae M, Takamura Y and Tamiya E (2006). Novel electrochemical identification and semi quantification of bovine constituents in feedstuffs. Sci. Tech. Adv. Mat. 7: 263-269.
http://dx.doi.org/10.1016/j.stam.2006.03.001
Embrey KJ, Searle MS and Craik DJ (1993). Interaction of Hoechst 33258 with the minor groove of the A + T-rich DNA duplex d(GGTAATTACC)2 studied in solution by NMR spectroscopy. Eur. J. Biochem. 211: 437-447.
http://dx.doi.org/10.1111/j.1432-1033.1993.tb17569.x
PMid:7679636
Fisker S, Hansen B, Fuglsang J, Kristensen K, et al. (2004). Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur. J. Endocrinol. 150: 773-777.
http://dx.doi.org/10.1530/eje.0.1500773
PMid:15191346
Hashimoto K, Ito K and Ishimori Y (1994). Sequence-specific gene detection with a gold electrode modified with DNA probes and an electrochemically active dye. Anal. Chem. 66: 3830-3833.
http://dx.doi.org/10.1021/ac00093a045
PMid:7528479
Horaková-Brazdilova P, Fojtova M, Vytras K and Fojta M (2008). Enzyme-Linked Electrochemical Detection of PCR-Amplified Nucleotide Sequences Using Disposable Screen-Printed Sensors. Applications in Gene Expression Monitoring. Sensors 8: 193-210.
http://dx.doi.org/10.3390/s8010193
Hudson BI, Carter AM, Harja E, Kalea AZ, et al. (2008). Identification, classification, and expression of RAGE gene splice variants. FASEB J. 22: 1572-1580.
http://dx.doi.org/10.1096/fj.07-9909com
PMid:18089847
Kobayashi M, Kusakawa T, Saito M, Kaji S, et al. (2004). Electrochemical DNA quantification based on aggregation induced by Hoechst 33258. Electrochem. Commun. 6: 337-343.
http://dx.doi.org/10.1016/j.elecom.2004.01.012
Latt SA and Stetten G (1976). Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J. Histochem. Cytochem. 24: 24-33.
http://dx.doi.org/10.1177/24.1.943439
PMid:943439
Lertwittayapon T (2010). Cloning of Soluble Receptor for Advanced Glycation Endproducts (sRAGE) Gene and Study the Effect of its Expressed Product on Liver Cancer Cell. Master's thesis. Chulalongkorn Uninversity, Bangkok.
Nagaev I and Smith U (2001). Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285: 561-564.
http://dx.doi.org/10.1006/bbrc.2001.5173
PMid:11444881
Scheller FW, Wollenberger U, Warsinke A and Lisdat F (2001). Research and development in biosensors. Curr. Opin. Biotechnol. 12: 35-40.
http://dx.doi.org/10.1016/S0958-1669(00)00169-5
Schmidt AM, Yan SD, Yan SF and Stern DM (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955.
PMid:11581294 PMCid:200958
Stern DM, Yan SD, Yan SF and Schmidt AM (2002). Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res. Rev. 1: 1-15.
http://dx.doi.org/10.1016/S0047-6374(01)00366-9
Sufen W, Tuzhi P and Yang CF (2002). Electrochemical studies for the interaction of DNA with an Irreversible redox compound-Hoechst 33258. Electroanalysis 14: 1648-1653.
http://dx.doi.org/10.1002/elan.200290006
Zhang FL, Gao HQ and Shen L (2007). Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. J. Cardiovasc. Pharmacol. 50: 434-440.
http://dx.doi.org/10.1097/FJC.0b013e3181342bfa
PMid:18049312